Tria Gets New Investors to Launch Skincare

Tria Beauty, Inc. announced the closing of$45.5 millionin new equity financing - with new investors, AmorePacific Ventures and Athyrium Capital Management. This latest round of equity financing was led by Bay City Capital.

The funds will be used to launch multiple new laser devices for skincare, including the company's first device in the largest skincare segment - anti-aging.

All major existing investors also participated in the equity financining, including Aisling Capital, DeNovo Ventures, Morgan Stanley Alternative Investment Partners, Vivo Ventures and Technology Partners.

"We have been investors in innovative companies bringing disruptive medical technologies and services to the market for some time. We see in Tria a unique combination of best-in-class technology, superior product design and a management team capable of scaling Tria into a dominant, global skincare brand," saidDick Pines, partner, Athyrium Capital Management.
Zoom Lebron XIV 14